Abbott's FreeStyle Libre glucose monitoring system approved in Australia

Abbott ($ABT) announced that it has received Australian approval for its FreeStyle Libre Flash Glucose Monitoring System, which eliminates the need for routine finger pricks. "We know through our research that pain, inconvenience and indiscretion of finger pricking were the key reasons people with diabetes aren't managing their diabetes as well as they should," said Abbott's senior vice president of diabetes care, Jared Watkin. "Addressing these concerns has guided the development of FreeStyle Libre--a transformational product designed to not only remove the pain of routine finger pricking but also seamlessly integrate into daily lives--empowering people with diabetes to make better-informed treatment decisions and live their best lives through better health." Release